Browsing Tag
Citi
43 posts
Hiscox (LSE: HSX) jumps 12% on Intact Financial takeover approach reports
Zurich just paid £8.1bn for Beazley. Now Intact Financial is circling Hiscox. The UK specialty insurance auction may have only just begun.
May 15, 2026
Megaport (ASX: MP1) surges 28% on $254m AI compute contracts: What comes next
Megaport said AI was the future. Today it signed $254 million of proof. The harder question is whether August's result can hold the re-rating.
May 14, 2026
IAG (LSE: IAG) jumps 6.4% as British Airways owner moves to wipe out €825m of bond dilution
Three days after a profit warning, IAG is buying back €825m of 2028 convertibles. The move kills 5.6% dilution before it happens, and the market noticed.
May 11, 2026
Fluence Energy stock jumps 32% as hyperscaler deals reset thesis: What FLNC investors need to watch next
Wall Street wrote off Fluence's Q2 revenue miss in minutes. Two hyperscaler supply deals and a $5.6B backlog flipped the thesis on US battery storage overnight.
May 8, 2026
Westpac shares run 3.1% as HY26 result and dividend chase fuel WBC bid
Westpac just delivered A$3.4bn profit and a 77c franked dividend. Brokers are still split between A$31 and A$40. The market has picked a side.
May 6, 2026
Circle Internet Group (NYSE: CRCL) jumps 16% on CLARITY Act stablecoin yield compromise
Tillis-Alsobrooks broke the stablecoin yield deadlock. CLARITY now has a path to law and Circle has a stacked catalyst week ahead of May 11 earnings.
May 5, 2026
Global Business Travel Group (NYSE: GBTG) jumps 57% on $6.3bn Long Lake Management buyout
Long Lake is paying $9.50 cash for Amex GBT. The 1.8 percent spread says the market trusts the deal closes. The harder question is what it signals next.
May 4, 2026
Arm Performix launches as Arm Holdings (NASDAQ: ARM) extends agentic AI play beyond silicon
Arm built the silicon. Now it wants to own the optimisation layer above it. Performix is free, agent-ready, and aimed squarely at the x86 migration question.
May 1, 2026
Ligand Pharmaceuticals (LGND) to acquire XOMA Royalty (XOMA) for $739m as biotech royalty consolidation accelerates
Ligand is buying XOMA for $739 million in cash. The real story sits inside a CVR tied to a $19.7 billion Johnson and Johnson royalty fight.
April 28, 2026
How the UK fell below NATO’s defence average and what it means for BAE and peers
Britain says it is rearming. NATO's 2025 data says London is now spending less of its economy on defence than Türkiye, and the gap is structural.
April 26, 2026